These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 22287152
1. Design, synthesis and biological evaluation of noncovalent inhibitors of human CD38 NADase. Zhou Y, Ting KY, Lam CM, Kwong AK, Xia J, Jin H, Liu Z, Zhang L, Cheung Lee H, Zhang L. ChemMedChem; 2012 Feb 06; 7(2):223-8. PubMed ID: 22287152 [No Abstract] [Full Text] [Related]
2. Identification by high-throughput screening of inhibitors of Schistosoma mansoni NAD(+) catabolizing enzyme. Kuhn I, Kellenberger E, Said-Hassane F, Villa P, Rognan D, Lobstein A, Haiech J, Hibert M, Schuber F, Muller-Steffner H. Bioorg Med Chem; 2010 Nov 15; 18(22):7900-10. PubMed ID: 20951593 [Abstract] [Full Text] [Related]
5. 4-alkoxy-3-arylfuran-2(5H)-ones as inhibitors of tyrosyl-tRNA synthetase: synthesis, molecular docking and antibacterial evaluation. Xiao ZP, Ouyang H, Wang XD, Lv PC, Huang ZJ, Yu SR, Yi TF, Yang YL, Zhu HL. Bioorg Med Chem; 2011 Jul 01; 19(13):3884-91. PubMed ID: 21669535 [Abstract] [Full Text] [Related]
6. Design and synthesis of 5,6-fused heterocyclic amides as Raf kinase inhibitors. Ramurthy S, Aikawa M, Amiri P, Costales A, Hashash A, Jansen JM, Lin S, Ma S, Renhowe PA, Shafer CM, Subramanian S, Sung L, Verhagen J. Bioorg Med Chem Lett; 2011 Jun 01; 21(11):3286-9. PubMed ID: 21543226 [Abstract] [Full Text] [Related]
9. The design, synthesis and biological evaluation of novel URB602 analogues as potential monoacylglycerol lipase inhibitors. Szabo M, Agostino M, Malone DT, Yuriev E, Capuano B. Bioorg Med Chem Lett; 2011 Nov 15; 21(22):6782-7. PubMed ID: 21982493 [Abstract] [Full Text] [Related]
12. Design, synthesis, and structural analysis of inhibitors of influenza neuraminidase containing a 2,3-disubstituted tetrahydrofuran-5-carboxylic acid core. Wang GT, Wang S, Gentles R, Sowin T, Maring CJ, Kempf DJ, Kati WM, Stoll V, Stewart KD, Laver G. Bioorg Med Chem Lett; 2005 Jan 03; 15(1):125-8. PubMed ID: 15582424 [Abstract] [Full Text] [Related]
13. Discovery of benzodihydroisofurans as novel, potent, bioavailable and brain-penetrant prolylcarboxypeptidase inhibitors. Shen HC, Ding FX, Jiang J, Verras A, Chabin RM, Xu S, Tong X, Chen Q, Xie D, Lassman ME, Bhatt UR, Garcia-Calvo MM, Geissler W, Shen Z, Murphy BA, Gorski JN, Wiltsie J, SinhaRoy R, Hale JJ, Pinto S, Shen DM. Bioorg Med Chem Lett; 2012 Feb 15; 22(4):1550-6. PubMed ID: 22264488 [Abstract] [Full Text] [Related]
14. Discovery and optimization of 7-aminofuro[2,3-c]pyridine inhibitors of TAK1. Hornberger KR, Berger DM, Crew AP, Dong H, Kleinberg A, Li AH, Medeiros MR, Mulvihill MJ, Siu K, Tarrant J, Wang J, Weng F, Wilde VL, Albertella M, Bittner M, Cooke A, Gray MJ, Maresca P, May E, Meyn P, Peick W, Romashko D, Tanowitz M, Tokar B. Bioorg Med Chem Lett; 2013 Aug 15; 23(16):4517-22. PubMed ID: 23850198 [Abstract] [Full Text] [Related]
18. Conformationally restricted hydantoin-based peptidomimetics as inhibitors of caspase-3 with basic groups allowed at the S3 enzyme subsite. Vázquez J, García-Jareño A, Mondragón L, Rubio-Martinez J, Pérez-Payá E, Albericio F. ChemMedChem; 2008 Jun 01; 3(6):979-85. PubMed ID: 18393268 [Abstract] [Full Text] [Related]